Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Glomerulosclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01665391
What this trial is testing

Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Primary Focal Segmental Glomerulosclerosis
Genzyme, a Sanofi Company 36
Not applicableLooking for participantsNCT07516964
What this trial is testing

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

Who this might be right for
Nephrotic Syndrome With Edema (Diagnosis)Minimal Change Nephrotic SyndromeFocal Segmental Glomerulosclerosis (FSGS)+1 more
Meyer Children's Hospital IRCCS 50
Not applicableLooking for participantsNCT01209000
What this trial is testing

Nephrotic Syndrome Study Network

Who this might be right for
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
University of Michigan 1,200
Testing effectiveness (Phase 2)Study completedNCT00098020
What this trial is testing

Podocyte Retinoids

Who this might be right for
Collapsing GlomerulopathyGlomerulosclerosis, Focal Segmental
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12
Testing effectiveness (Phase 2)WithdrawnNCT00550342
What this trial is testing

Rituximab Treatment of Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not applicableLooking for participantsNCT06760845
What this trial is testing

Raman Spectroscopy Diagnosis of Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Membranous NephropathyDiabetic Nephropathy+1 more
Zunsong Wang 200
Not applicableLooking for participantsNCT03929887
What this trial is testing

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Who this might be right for
Glomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more
Seoul National University Hospital 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Not applicableStudy completedNCT04389827
What this trial is testing

Global Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
The George Institute 5,999
Testing effectiveness (Phase 2)Ended earlyNCT04387448
What this trial is testing

TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Who this might be right for
Kidney DiseasesDiabetic NephropathiesGlomerulosclerosis, Focal Segmental+8 more
Goldfinch Bio, Inc. 96
Post-approval studies (Phase 4)Study completedNCT02633046
What this trial is testing

Acthar for Treatment-Resistant or Treatment-Intolerant Proteinuria

Who this might be right for
Idiopathic Focal Segmental Glomerulosclerosis
Mallinckrodt ARD LLC 63
Testing effectiveness (Phase 2)Ended earlyNCT05441826
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Minimal Change DiseaseFocal Segmental Glomerulosclerosis
Tenet Medicines 1
Not applicableUnknownNCT06443034
What this trial is testing

Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisAPOL1 Associated Kidney Disease
Assistance Publique - Hôpitaux de Paris 124
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Testing effectiveness (Phase 2)Study completedNCT00001959
What this trial is testing

Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)

Who this might be right for
FibrosisFocal GlomerulosclerosisKidney Failure+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 21
Large-scale testing (Phase 3)Study completedNCT02683889
What this trial is testing

Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation

Who this might be right for
FSGS
University of Colorado, Denver 15
Not applicableLooking for participantsNCT05650619
What this trial is testing

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more
University of Michigan 300
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Not applicableStudy completedNCT03126201
What this trial is testing

Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis

Who this might be right for
GlomerulonephritisFocal Segmental Glomerulosclerosis
Istanbul University 86
Next Page